News

ORNL researcher Louise Evans is working to ensure safeguards approaches and verification technologies are integrated early in the design process of advanced reactor technologies. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
Decades of nuclear expertise guides global nonproliferation innovation
To turn carbon dioxide, or CO2, into methanol, or CH3OH, copper (shown in yellow) on a hydride-substituted support speeds reactions mediated by hydrides and catalyzed by hydrogen atoms (shown in black) from surface-adsorbed formate, HCOO*. Credit: Yang He/ORNL, U.S. Dept. of Energy
Ion swap improves CO2-defeating catalyst
Caption: The Na-CO2 battery developed at ORNL, consisting of two electrodes in a saltwater solution, pulls atmospheric carbon dioxide into its electrochemical reaction, and releases only valuable biproducts. Credit: Andy Sproles/ORNL, U.S. Dept. of Energy
Carbon-capture batteries store renewable energy

Filter News

Area of Research

News Type

Date

News Topics

Media Contacts

Connect with ORNL

Oak Ridge National Laboratory’s MENNDL AI software system can design thousands of neural networks in a matter of hours. One example uses a driving simulator to evaluate a network’s ability to perceive objects under various lighting conditions. Credit: ORNL, U.S. Dept. of Energy

ORNL licenses revolutionary AI system to General Motors for automotive use

The Department of Energy’s Oak Ridge National Laboratory has licensed its award-winning artificial intelligence software system, the Multinode Evolutionary Neural Networks for Deep Learning, to General Motors for use in vehicle technology and design.

Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy

Neutrons reveal unpredicted binding between SARS-CoV-2, hepatitis C antiviral drug

Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.